Skip to main content
INQOVI 100 mg/1, 35 mg/1 tablet, film coated by Taiho Pharmaceutical Co., Ltd.
INQOVI, 100 mg/1, 35 mg/1, tablet, film coated Drug class: Nucleoside Metabolic Inhibitor. Available on prescription only. Listed by Taiho Pharmaceutical Co., Ltd..
Prescription only

INQOVI

CEDAZURIDINE and DECITABINE

Listed by Taiho Pharmaceutical Co., Ltd.

Strength
100 mg/1, 35 mg/1
Form
Tablet, Film Coated
Route
Oral
Class
Nucleoside Metabolic Inhibitor

What it contains

  • Cedazuridine 100 mg/1
  • Decitabine 35 mg/1

This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.

FDA record

Dosage form Tablet, Film Coated
Route Oral
Drug class Nucleoside Metabolic Inhibitor
Approval route NDA — original brand approval
NDC code 64842-0727
FDA application NDA212576
RxNorm concept 2384457
Package sizes listed 1
Marketed since July 2020

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.